NM_006411.4:c.*282G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_006411.4(AGPAT1):c.*282G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0159 in 507,700 control chromosomes in the GnomAD database, including 104 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.015   (  30   hom.,  cov: 32) 
 Exomes 𝑓:  0.016   (  74   hom.  ) 
Consequence
 AGPAT1
NM_006411.4 3_prime_UTR
NM_006411.4 3_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  1.44  
Publications
6 publications found 
Genes affected
 AGPAT1  (HGNC:324):  (1-acylglycerol-3-phosphate O-acyltransferase 1) This gene encodes an enzyme that converts lysophosphatidic acid (LPA) into phosphatidic acid (PA). LPA and PA are two phospholipids involved in signal transduction and in lipid biosynthesis in cells. This enzyme localizes to the endoplasmic reticulum. This gene is located in the class III region of the human major histocompatibility complex. Alternative splicing results in two transcript variants encoding the same protein. [provided by RefSeq, Jul 2008] 
 PPT2-EGFL8  (HGNC:48343):  (PPT2-EGFL8 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring PPT2 (palmitoyl-protein thioesterase 2) and EGFL8 (EGF-like-domain, multiple 8) genes located in the major histocompatibility complex class III region of chromosome 6. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65). 
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0151 (2289/152074) while in subpopulation NFE AF = 0.0246 (1672/67966). AF 95% confidence interval is 0.0236. There are 30 homozygotes in GnomAd4. There are 1077 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 30  gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| AGPAT1 | NM_006411.4 | c.*282G>A | 3_prime_UTR_variant | Exon 7 of 7 | ENST00000375107.8 | NP_006402.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0151  AC: 2289AN: 151956Hom.:  30  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2289
AN: 
151956
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0163  AC: 5788AN: 355626Hom.:  74  Cov.: 0 AF XY:  0.0155  AC XY: 2853AN XY: 183702 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
5788
AN: 
355626
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
2853
AN XY: 
183702
show subpopulations 
African (AFR) 
 AF: 
AC: 
43
AN: 
11182
American (AMR) 
 AF: 
AC: 
118
AN: 
15358
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
56
AN: 
11672
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
27126
South Asian (SAS) 
 AF: 
AC: 
12
AN: 
28070
European-Finnish (FIN) 
 AF: 
AC: 
444
AN: 
23768
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
1654
European-Non Finnish (NFE) 
 AF: 
AC: 
4829
AN: 
215222
Other (OTH) 
 AF: 
AC: 
286
AN: 
21574
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 266 
 531 
 797 
 1062 
 1328 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0151  AC: 2289AN: 152074Hom.:  30  Cov.: 32 AF XY:  0.0145  AC XY: 1077AN XY: 74348 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2289
AN: 
152074
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1077
AN XY: 
74348
show subpopulations 
African (AFR) 
 AF: 
AC: 
178
AN: 
41470
American (AMR) 
 AF: 
AC: 
197
AN: 
15296
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
13
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5174
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
4810
European-Finnish (FIN) 
 AF: 
AC: 
199
AN: 
10576
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
1672
AN: 
67966
Other (OTH) 
 AF: 
AC: 
29
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 111 
 223 
 334 
 446 
 557 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 26 
 52 
 78 
 104 
 130 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
4
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.